Related Experiment Videos
Pharmacologic management of atrial fibrillation
1Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.
Insights
Pharmacologic therapies are crucial for managing atrial fibrillation (AF), regardless of whether it is episodic or permanent. This review covers drug strategies for rate control, rhythm restoration, AF reduction, and preventing blood clots.
Area of Science:
- Cardiology
- Pharmacology
- Electrophysiology
Background:
- Drugs remain central to atrial fibrillation (AF) management, despite advances in invasive procedures and devices.
- Atrial fibrillation can manifest as episodic or permanent rhythm disorders, with similar prognoses.
- Considering both forms as part of a disease spectrum is clinically relevant.
Purpose of the Study:
- To review pharmacologic strategies for treating atrial fibrillation.
- To outline approaches for managing ventricular response, restoring sinus rhythm, and reducing AF recurrence.
- To discuss the prevention of thromboembolic complications associated with atrial fibrillation.
Main Methods:
- Literature review of pharmacologic treatments for atrial fibrillation.
- Analysis of drug mechanisms for rate control, rhythm control, and thromboembolic prophylaxis.
- Brief overview of nonpharmacologic treatment options for atrial fibrillation.
Main Results:
- Pharmacologic agents are essential for controlling ventricular rate in AF.
- Drugs can be used to restore and maintain normal sinus rhythm.
- Anticoagulant therapy is critical for preventing stroke in AF patients.
Conclusions:
- Pharmacologic management is the cornerstone of atrial fibrillation treatment.
- A comprehensive approach includes rate control, rhythm control, and thromboembolic prevention.
- Nonpharmacologic therapies complement drug treatments for AF.
Abstract:
In an era when many electrophysiologic problems are routinely treated with invasive procedures or implantable devices, drugs remain the cornerstones of treatment for atrial fibrillation. Atrial fibrillation may present as an episodic rhythm in patients who are primarily in sinus rhythm or it may be manifested as rhythm disorder that is permanent. Patients who appear to have an episodic rhythm disorder may be found to be in atrial fibrillation permanently when followed for long periods of time, and prognosis in the two forms is similar. It is, therefore, useful to consider them different manifestations in the same spectrum of disease. This review will address pharmacologic approaches designed to: (1) slow ventricular response; (2) restore sinus rhythm; (3) reduce occurrences of atrial fibrillation; and (4) prevent thromboembolic complications. Nonpharmacologic approaches to treating atrial fibrillation will be briefly reviewed.